Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to 0.36.

  • Fortress Biotech's Equity Ratio rose 45849.8% to 0.36 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.36, marking a year-over-year increase of 45849.8%. This contributed to the annual value of 0.16 for FY2024, which is 1715.2% up from last year.
  • Latest data reveals that Fortress Biotech reported Equity Ratio of 0.36 as of Q3 2025, which was up 45849.8% from 0.27 recorded in Q2 2025.
  • Fortress Biotech's 5-year Equity Ratio high stood at 0.62 for Q1 2021, and its period low was 0.1 during Q3 2024.
  • Moreover, its 5-year median value for Equity Ratio was 0.18 (2025), whereas its average is 0.23.
  • Its Equity Ratio has fluctuated over the past 5 years, first crashed by 13181.89% in 2024, then surged by 86293.26% in 2025.
  • Fortress Biotech's Equity Ratio (Quarter) stood at 0.57 in 2021, then plummeted by 70.16% to 0.17 in 2022, then dropped by 20.83% to 0.13 in 2023, then increased by 17.15% to 0.16 in 2024, then surged by 127.93% to 0.36 in 2025.
  • Its Equity Ratio stands at 0.36 for Q3 2025, versus 0.27 for Q2 2025 and 0.18 for Q1 2025.